用于抗癌治疗的生物异质替代和醇结合衍生物的药理学评估
Dipesh Kumar1, Salahuddin1, Avijit Mazumder1
1Department of Pharmaceutical Chemistry, Noida Institute of Engineering and Technology (Pharmacy Institute), Plot no. 19, Knowledge Park-2, Greater Noida, 201306, Uttar Pradesh, India.
概括
本综述探讨了以三醇为基础的化合物作为新型抗癌剂. 与当前的癌症疗法相比,这些混合药物显示出降低毒性和提高功效的潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 有机化学 有机化学
背景情况:
- 癌症仍然是全球死亡的主要原因,目前的治疗方法面临毒性和耐药性等挑战.
- 对于具有更好的疗效和安全性概况的新型抗癌药物有着迫切的需求.
- 三醇分类为开发新的混合抗癌药物提供了一个有前途的支架.
研究的目的:
- 审查基于三醇的抗癌药物的最新进展.
- 分析这些化合物的化学结构,作用机制和结构-活性关系.
- 突出三醇衍生混合药物的临床和非临床试验.
主要方法:
- 关于从2000年代初到2020年代发表的文章的文献综述.
- 分析三醇部分的化学结构和整合策略.
- 检查目标受体/酶和作用机制.
- 评估结构-活性关系和临床试验数据.
主要成果:
- 通过生物异构体替代,点击化学和有机催化剂的三醇合并产生了强大的抗癌药物.
- 许多基于三醇的衍生物对各种癌症类型表现出有前途的抗癌活性.
- 几种混合药物正在通过临床和非临床试验取得进展,证明其治疗潜力.
结论:
- 基于triazole的混合药物代表了抗癌疗法开发的重大进步.
- 这些新型药物为克服现有治疗方法的局限性提供了一个有希望的策略,包括降低毒性和提高功效.
- 对三醇衍生物的持续研究对于开发下一代癌症疗法至关重要.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K


